Drawing for NANOSTATIC PROTECTIVE SURFACE

USPTO serial 79432456

NANOSTATIC PROTECTIVE SURFACE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
EISNACH, MICHAEL PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with NANOSTATIC PROTECTIVE SURFACE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Surgical apparatus and instruments; medical apparatus and instruments for the treatment of wounds, burns, ulcers, damaged skin and tissue, joint and musculo-skeletal diseases and disorders; medical and veterinary apparatus and instruments for separating human and animal tissues and cells; artificial limbs, eyes and teeth; suture materials; diagnostic apparatus for medical cosmetic and veterinary purposes used in medical laboratories namely apparatus for blood analysis; apparatus and instruments for separating human and animal tissues and cells dispersion devices of biological material for preparing cellular suspension and microinsert of tissue; apparatus for testing blood and tissue samples for medical laboratories for handling biologic materials; medical devices for the care of diseases concerning human tissues in the nature of apparatus and instruments for blood collecting, blood processing and blood injection and for veterinary medicine blood testing apparatus; medical devices for the care of diseases concerning human tissues in the nature of coatings sold as an integral component of tubes for blood collecting, blood processing and blood injection; cannulae; catheters; haemocytometers; injectors for medical purposes, namely, syringes for medical use; glass tubes for medical purposes, namely, blood collection tubes; glass tubes for medical purposes, glass capillary tubes; centrifuges for medical use; kits primarily consisting of apparatus in the nature of syringes, tubes, vials, containers for tissue and blood collection, separation of tissue and blood components, tissue and blood processing, and re-injection of tissue and blood for medical purposes; applicators and devices for the administration of pharmaceutical preparations and medicines, namely, syringes for medical use; automated blood component separation apparatus for medical use and instruments; apparatus and instruments for the recovery of autologous blood, namely, blood drawing apparatus for autologous blood; blood processing apparatus and instruments, namely apparatus for collecting blood; apparatus and instruments for preparing PRP (platelet-rich plasma); medical instruments for cutting tissues; bags for endoscopic retrieval of tissue; ultrasonic aspirators for separating soft tissue parts; medical implants consisting of artificial materials; artificial implants; biodegradable implants consisting of artificial materials; needles for surgical purposes; needles for medical purposes; syringes for surgical use; syringes for medical use; bags for collecting body fluids; suction bags for medical use; wound drainage pouches; filters and membranes for filtration, namely, blood filters for medical use.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2026RFNTREFUSAL PROCESSED BY IB
Jan 4, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 4, 2026RFRRREFUSAL PROCESSED BY MPU
Nov 25, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2025DOCKASSIGNED TO EXAMINER
Sep 16, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Sep 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance